COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS
申请人:Olsson Roger
公开号:US20090176837A1
公开(公告)日:2009-07-09
Disclosed herein are novel compounds with activity at RARβ 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.